C533 (Tenofovir Disoproxil Fumarate 300 mg)
Pill with imprint C533 is Blue, Capsule-shape and has been identified as Tenofovir Disoproxil Fumarate 300 mg. It is supplied by Cipla USA Inc.
Tenofovir is used in the treatment of hepatitis b; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Tenofovir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C533
Tenofovir Disoproxil Fumarate
- Imprint
- C533
- Strength
- 300 mg
- Color
- Blue
- Size
- 17.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA Inc.
- National Drug Code (NDC)
- 69097-0533
- Inactive Ingredients
-
lactose monohydrate,
croscarmellose sodium,
corn starch,
polysorbate 80,
microcrystalline cellulose,
magnesium stearate,
titanium dioxide,
triacetin,
FD&C Blue No. 2,
hypromellose 2910 (15 mPa.s)
Note: Inactive ingredients may vary.
More about tenofovir
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (23)
- Drug images
- Compare alternatives
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Patient resources
- Drug Information
- Tenofovir (Advanced Reading)
- Tenofovir Disoproxil Fumarate Tablets
- Tenofovir Disoproxil Fumarate Oral Powder
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.